G1 Therapeutics, Inc.
SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE
Last updated:
Abstract:
This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
Status:
Application
Type:
Utility
Filling date:
24 Feb 2021
Issue date:
17 Jun 2021